Table 1. Characteristics of data sets and patients included in this study.
| Data set | Data source | Platform description | GEO platform ID | No. of patients |
|---|---|---|---|---|
| Korean cohort | GSE16757 | Illumina Human-6 v2.0 | GPL6102 | 100 |
| Fudan cohort | GSE14520 | Affymetrix Human Genome U133A Array | GPL571/GPL3921 | 242 |
| TCGA cohort | a | Illumina RNA-seq | NA | 331 |
| PAAD | GSE21501 | Agilent-014850 Whole Human Genome Microarray | GPL4133 | 102 |
| LUAD | GSE31210 | Affymetrix Human Genome U133 Plus 2.0 Array | GPL570 | 226 |
| BRCA | GSE20486 | Illumina HumanHT-12 V3.0 | GPL6947 | 81 |
| BLCA | GSE13507 | Illumina Human-6 v2.0 | GPL6102 | 165 |
| Pan-cancer cohort | a | Illumina RNA-seq | NA | 2,066 |
Abbreviations: BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; GEO, National Center for Biotechnology Information’s Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/); LUAD, lung adenocarcinoma; PAAD, pancreatic adenocarcinoma.
a
UCSC Cancer Genome Browser (https://genome-cancer.ucsc.edu).